Newsroom Subscribe Contact

About us

About us

Company Overview Team Careers

Our Science

Our Science

Pipeline

Pipeline

Investors

Investors

Investor Overview Press Releases Events + Presentations Company Information SEC Filings Stock Information Corporate Governance News Alerts

In the News

Enveric Biosciences Buys MagicMed In All Stock Deal Valued At $30 Million [The Green Market Journal]

May 24, 2021

Enveric Biosciences Buys MagicMed In All Stock Deal Valued At $30 Million

Company Science Investors News & Media Contact

Sign up for free updates:

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

© 2023 Enveric Biosciences | Terms of Use | Privacy Policy

Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.